VEGFA and age-related macular degeneration: Coronado et al. [100] designed a pilot prospect study to estimate the protein profiles of AMD patients with good responses to anti-VEGF agents (n = 5), poor responses to anti-VEGF agents (n = 5), and of healthy controls (n = 5).